Oncology and emerging markets key targets for Astellas
This article was originally published in Scrip
Executive Summary
Oncology and the emerging pharma markets provided much of the focus of a regular press briefing by Astellas president and CEO Masafumi Nogimori in Tokyo, at which the executive highlighted the company's efforts to build up its presence in both sectors.